Novo Nordisk’s stock rises 10% by end of 2026 due to Wegovy pill demand
Resolves: Novo Nordisk’s stock price closes at or above 110% of its 2026-07-06 closing price on the last trading day of 2026.
user-generated· earnings
Novo Nordisk’s stock rises 10% by end of 2026 due to Wegovy pill dema…
Market overview
Novo Nordisk’s stock is expected to benefit from increased demand for the oral Wegovy pill in the UK, which offers a needle-free alternative to the injectable version. Analysts project that the convenience factor will drive higher adoption rates among consumers.
earnings prediction market
- Implied probability (Yes)
- 70%
- Closes
- 2026-12-31
About this prediction
Resolution criteria
Novo Nordisk’s stock price closes at or above 110% of its 2026-07-06 closing price on the last trading day of 2026.
Source: user-generated
More earnings markets
- Will cash burn exceed $5M in Q4? — 65% Yes
- Will Venyra beat Q4 2026 revenue consensus of $230M? — 85% Yes
- Will Nuburu secure emergency financing by Q3 end? — 35% Yes
- Will Everpure, Inc. report a non-GAAP EPS beat for the quarter ended June 30, 2026? — 50% Yes
- Will KR miss Q4 operating margin guidance? — 65% Yes
- Will George Risk report Q4 2026 revenue above $13M? — 85% Yes
- Will DCI beat Q4 EPS consensus of $0.88? — 65% Yes
- Will inventory days decrease below 70 by year-end? — 40% Yes
No one's made a Conviction call on this yet. Be the first to call it →
Loading…